Post-earnings recap
Reported
Wed, Feb 26, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
Despite reporting a loss in EPS, Moderna's stock surged by 22.73% following the earnings report. This increase suggests that investors are optimistic about the company's future potential, particularly in its research and development pipeline. The management's positive tone likely contributed to this strong stock performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.37 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a positive outlook on their long-term strategy despite the current EPS miss. They emphasized their commitment to innovation and growth.
Management expressed excitement about ongoing research and development efforts.
They highlighted the importance of their pipeline in addressing future health needs.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—